This capital infusion is likely to be viewed positively by investors as it provides Eledon Pharmaceuticals with additional resources for operations, research, and development. The sale of shares and warrants increases the company's cash reserves, potentially funding future growth or stabilizing its financial position. However, the impact on stock price will depend on market perception of this capital raise's necessity and potential dilution effects.